INVESTORS Annual Reports Financials Investor Presentations Shareholder Information Analysts Speak Events Companies Act Policies
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
MEDIA Press Releases Downloadables
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers
Lupin receives FDA approval for generic Temovate Ointment, 0.05%

VIEW ALL PRESS RELEASESS